<SEC-DOCUMENT>0001213900-26-090377-index.html : 20260817
<SEC-HEADER>0001213900-26-090377.hdr.sgml : 20260817
<ACCEPTANCE-DATETIME>20260814205224
ACCESSION NUMBER: 0001213900-26-090377
CONFORMED SUBMISSION TYPE: 424B3
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20260817
DATE AS OF CHANGE: 20260814

FILER:

 COMPANY DATA: 
 COMPANY CONFORMED NAME: Enlivex Ltd.
 CENTRAL INDEX KEY: 0001596812
 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
 ORGANIZATION NAME: 03 Life Sciences
 EIN: 000000000
 STATE OF INCORPORATION: L3
 FISCAL YEAR END: 1231

 FILING VALUES:
 FORM TYPE: 424B3
 SEC ACT: 1933 Act
 SEC FILE NUMBER: 333-298071
 FILM NUMBER: 261284446

 BUSINESS ADDRESS: 
 ADDRESS IS A NON US LOCATION: YES
 STREET 1: 37 DEREH MENACHEM BEGIN ST.
 STREET 2: 15TH FLOOR
 CITY: TEL AVIV
 PROVINCE COUNTRY: L3
 BUSINESS PHONE: 972 (0) 3 7326616

 MAIL ADDRESS: 
 ADDRESS IS A NON US LOCATION: YES
 STREET 1: 37 DEREH MENACHEM BEGIN ST.
 STREET 2: 15TH FLOOR
 CITY: TEL AVIV
 PROVINCE COUNTRY: L3

 FORMER COMPANY: 
 FORMER CONFORMED NAME: Enlivex Therapeutics Ltd.
 DATE OF NAME CHANGE: 20190326

 FORMER COMPANY: 
 FORMER CONFORMED NAME: Bioblast Pharma Ltd.
 DATE OF NAME CHANGE: 20160919

 FORMER COMPANY: 
 FORMER CONFORMED NAME: BIO BLAST PHARMA LTD.
 DATE OF NAME CHANGE: 20140113
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea0301916-424b3_enlivex.htm
<DESCRIPTION>PROSPECTUS
<TEXT>
Document 1 - file: ea0301916-424b3_enlivex.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ea030191601_img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: ea030191601_img1.jpg

</DOCUMENT>
</SEC-DOCUMENT>